Viewing Study NCT00577915


Ignite Creation Date: 2025-12-18 @ 8:22 AM
Ignite Modification Date: 2025-12-23 @ 9:56 PM
Study NCT ID: NCT00577915
Status: None
Last Update Posted: 2016-11-29 00:00:00
First Post: 2007-12-18 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Breast MRI Spectroscopy
Sponsor: None
Organization:

Study Overview

Official Title: Breast MRI Spectroscopy
Status: None
Status Verified Date: 2016-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Our aim is to perform MR Spectroscopy (MRS) on 150 evaluable patients at the end of their routine breast MRI examination using a software package from General Electric Medical Systems Milwaukee, WI). This will add time to the routine examination but will not involve additional injections of contrast. We will analyze the spectroscopic data to determine if benign lesions can be reliably differentiated from malignant ones.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: